(Total Views: 600)
Posted On: 03/12/2021 11:37:26 AM
Post# of 153832
“How nice of Dr. Patterson to tell you that. Oh he didn't, it's third party hearsay. Sounds about as accurate as Dr. Patterson personally contacting CDiddy.”
I’ve done my DD, it’s a fact. You’d be subsided who will answer simple questions if you call or email them. You can discount it however you choose, but CYDY is in violation of the contract that CYDY and Incelldx signed in 2019 and therefore, the RO data is not available to them. I’ve said many times that I believe the rift started when Incelldx filed a patent for the CCR5/CCL5 treatment pathway for COVID nearly a year ago. This is standard industry practice, especially when the company discovers the treatment pathway, whether they own a drug for that pathway or not.
Just an FYI, Incelldx also has RO data from the M2M trial and part of the S/C trial.
I’ve done my DD, it’s a fact. You’d be subsided who will answer simple questions if you call or email them. You can discount it however you choose, but CYDY is in violation of the contract that CYDY and Incelldx signed in 2019 and therefore, the RO data is not available to them. I’ve said many times that I believe the rift started when Incelldx filed a patent for the CCR5/CCL5 treatment pathway for COVID nearly a year ago. This is standard industry practice, especially when the company discovers the treatment pathway, whether they own a drug for that pathway or not.
Just an FYI, Incelldx also has RO data from the M2M trial and part of the S/C trial.
(3)
(0)
